Company Overview
Oxford University Clinical Research Unit (OUCRU) is a large-scale clinical and public health research unit focused on infectious diseases.
Founded in 1991, OUCRU has grown into a region-wide programme with offices in Vietnam, Indonesia and Nepal. Our work is powered by a team of 500 researchers and research-support staff.
We are proudly part of the Centre for Tropical Medicine and Global Health at the University of Oxford (UK). OUCRU is a Wellcome Major International Programme.
Local Research - Global Impact
For over 30 years, OUCRU has made a lasting impact across Southeast Asia by leading locally-driven research into infectious diseases prevalent in the region.
In collaboration with local partners and host organisations, we conduct multi-disciplinary laboratory and clinical research, engaging with hospital and community-based populations. Drawing on fields such as epidemiology, immunology, microbiology, mathematical modelling, biostatistics, and social science, we provide nuanced findings for complex health challenges.
Our dedicated Clinical Trials Unit and Data Management Centres ensure that our research adheres to strict national and international standards.
Building Collaborative Communities for Research Impact
Infectious diseases are becoming increasingly complex, and addressing them requires global collaboration. At OUCRU, we recognise the importance of building strong networks that bring together governments, policymakers, academic institutions, the private sector, nonprofits and local communities.
We welcome partnerships that enhance research infrastructure, build capacity, and improve disease forecasting and response systems. We are also keen to explore new technologies to create impactful and accessible healthcare solutions, especially for those living in resource-limited areas.
Research Highlight
Here’s a look at some of our recent work:
• SEACOVARIANTS: Developed a regional platform for rapid assessment of SARS-CoV-2 variants, providing crucial data for policymakers.
• Shaping Global Antimicrobial Resistance (AMR) Research Priorities: Contributed to WHO’s new AMR priorities, guiding global research for the next five years.
• Historic Malaria Vaccine Trial: Completed Indonesia’s first malaria vaccine trial, showing promising results for global malaria control.
